Recent evidence from African countries indicates that DMPA-SC may help reduce service delivery costs by catalyzing community-based distribution and remote provision of injectable contraception. Moreover, self-injection of DMPA-SC—when compared with clinic administration of traditional injectables—is not just cost-effective but cost saving when accounting for costs to both women and health systems.

Global male life expectancy is four years lower than female and the ‘sex gap’ is widening. There are also significant variations in men’s health outcomes between and within countries. Improved men’s self-care practices would result in better health for men as well as for women and children. They would also help achieve UN’s SDGs and reduce costs for health systems.